Skip to main content
SpringerLink
Log in

Iatrogene Störungen

  • Chapter
Book cover Medizin des Alterns und des alten Menschen

Zusammenfassung

Im Pschyrembel wird unter iatrogen „durch den Arzt verursacht“ verstanden, „z.B. infolge diagnostischer oder therapeutischer Einwirkungen“. Eine andere Definition für iatrogene Krankheit („iatrogenic illness“) versteht hierunter allgemein jeden krankhaften Zustand, der aus einer diagnostischen oder irgendeiner therapeutischen Maßnahme folgt. Dies schließt schädigende Ereignisse ein, die nicht als „natürliche Folge“ der Erkrankungen des Patienten anzusehen sind, z.B. Stürze und Dekubitalulzera. Synonym wird auch der Begriff „iatrogene Komplikation“ verwendet. Eine neuere Definition beruht auf der Zugrundelegung von 3 Kriterien:

  1. 1.

    der Kausalität

  2. 2.

    der messbaren Behinderung und

  3. 3.

    der fehlenden Absicht.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ancelin ML, Artero S, Portet F, Dupuy A-M, Touchon J (2006) Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332:455–458

    Article  PubMed  Google Scholar 

  2. Arzneimittelkommission der Deutschen Ärzteschaft (2005) Pharmakovigilanz. Arzneiverordnung in der Praxis, Band 32, Sonderheft 1

    Google Scholar 

  3. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. J Am Med Ass 294:716–724

    Article  CAS  Google Scholar 

  4. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH (1991) Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 324:370–376

    PubMed  CAS  Google Scholar 

  5. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL (2006) National surveillance of emergency department visits for outpatient adverse drug events. J Am Med Ass 296:1858–1866

    Article  CAS  Google Scholar 

  6. Bundesministerium für Familie und Senioren (1992) Hilfe-und Pflegebedarf in Deutschland 1991. Schnellbericht zur Repräsentativerhebung im Rahmen des Forschungsprojekts „Möglichkeiten und Grenzen selbständiger Lebensführung“, durch Infratest Sozialforschung und Infratest Epidemiologie und Gesundheitsforschung, München

    Google Scholar 

  7. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259

    Article  PubMed  CAS  Google Scholar 

  8. Egger T, Dorman H, Ahne G, Runge U, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K (2003) Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 20:769–776

    Article  PubMed  CAS  Google Scholar 

  9. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers Criteria for potentially inappropriate medication in older adults. Arch Intern Med 163:2716–2724

    Article  PubMed  Google Scholar 

  10. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW (2003) Adverse drug events in ambulatory care. N Engl J Med 348:1556–1564

    Article  PubMed  Google Scholar 

  11. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. J Am Med Ass 289:1107–1116

    Article  Google Scholar 

  12. Haynes RB (1982) Einleitung. In: Haynes, Taylor, Sockett (Hrsg) Compliance Handbuch. Übersetzt und bearbeitet von A. Schrey unter Mitarbeit von E.A. Noack. Oldenbourg, München Wien, S 11–18

    Google Scholar 

  13. Haynes RB, Yao X, Degani A et al (2007) Interventions for enhancing medication adherence (review). The Cochrane Library, http://www.thecochranelibrary.com

    Google Scholar 

  14. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330(13):877–884

    Article  PubMed  CAS  Google Scholar 

  15. Klein LE, German PS, Levine DM, Feroli ER, Ardery J (1984) Medication problems among outpatients. A study with emphasis on the elderly. Arch Intern Med 144:1185–1188

    Article  PubMed  CAS  Google Scholar 

  16. Köhler GI, Bode-Böger SM, Busse R, Hoopmann M, Weite T, Böger RH (2000) Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 38:504–513

    PubMed  Google Scholar 

  17. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. J Am Med Ass 279:1200–1205

    Article  CAS  Google Scholar 

  18. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H (1991) The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 324:377–384

    PubMed  CAS  Google Scholar 

  19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470

    PubMed  CAS  Google Scholar 

  20. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139(2):137–147

    PubMed  Google Scholar 

  21. National Kidney Foundation (2002) K/DOQI (Kidney Disease Outcome Quality Inititive) clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):1–266

    Google Scholar 

  22. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabai R, Gambassi (2002) Adverse drug reactions as cause of hospital admisssions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50:1962–1968

    Article  PubMed  Google Scholar 

  23. Pedone C, Corsonello A, Incalzi RA for The GIFA Investigators (2006) Estimating renal function in older people: a comparison of three formulas. Age Ageing 35:121–126

    Article  PubMed  Google Scholar 

  24. Renteln-Kruse W von (2000) Iatrogene Störungen. In: Nikolaus T (Hrsg) Klinische Geriatrie. Springer, Berlin Heidelberg New York, S 410–417

    Google Scholar 

  25. Schmiedl S, Szymanski J, Rottenkolber M, Drewelow B, Haase G, Hippius M, Reimann IR, Siegmund W, May K, Haack S, Hasford J, Thürmann PA (2007) Fingerhut — ein alter Hut? Eine Analyse stationärer Aufnahmen durch digitalisassoziierte unerwünschte Arzneimittelwirkungen. Med Klinik 102:603–611

    Article  Google Scholar 

  26. Shelton PS, Fritsch MA, Scott MA (2000) Assessing medication appropriateness in the elderly. A review of available measures. Drugs Aging 16:437–450

    Article  PubMed  CAS  Google Scholar 

  27. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, HanIon JT (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173–184

    Article  PubMed  Google Scholar 

  28. Thomas EJ, Brennan TA (2000) Incidence and types of preventable adverse events in elderly patients: population based review of medical records. Br Med J 320:741–747

    Article  CAS  Google Scholar 

  29. Tinetti ME, Bogardus ST, Agostini JV (2004) Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 351:2870–2874

    Article  PubMed  CAS  Google Scholar 

  30. Weingart SN, Wilson RMcL, Gibberd RW, Harrison B (2000) Epidemiology of medical error. Br Med J 320:774–777

    Article  CAS  Google Scholar 

  31. Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD (1995) The Quality in Australian Health Care Study. Med J Aust 163:458–471

    PubMed  CAS  Google Scholar 

  32. Wrenger E, Müller R, Moesenthin M, Welte T, Fröhlich JC (2003) Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. Br Med J 327:147–149

    Article  CAS  Google Scholar 

  33. Wucherpfennig G, Meier-Baumgartner HP, Görres S (1988) Prospektive Studie zur Digitalisintoxikation in der Geriatrie. Z Geriatrie 1:95–100

    Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Medizinisch Geriatrische Klinik Albertinen-Haus Zentrum für Geriatrie und Gerontologie, Wiss. Einrichtung an der Universität Hamburg, Sellhopsweg 18-22, 22459, Hamburg

    Wolfgang v. Renteln-Kruse

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Steinkopff Verlag

About this chapter

Cite this chapter

(2009). Iatrogene Störungen. In: v. Renteln-Kruse, W. (eds) Medizin des Alterns und des alten Menschen. Steinkopff. https://doi.org/10.1007/978-3-7985-1727-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-7985-1727-1_6

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1726-4

  • Online ISBN: 978-3-7985-1727-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation